Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

17 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Healthcare resource utilization and healthcare costs in patients with type 2 diabetes mellitus initiating sodium-glucose cotransporter 2 inhibitors vs dipeptidyl peptidase-4 inhibitors in Japan: A real-world administrative database analysis.
Kashiwagi A, Shoji S, Kosakai Y, Yoshinaga Y, Rokuda M. Kashiwagi A, et al. Among authors: rokuda m. J Diabetes Investig. 2024 Mar;15(3):374-387. doi: 10.1111/jdi.14123. Epub 2023 Dec 19. J Diabetes Investig. 2024. PMID: 38112598 Free PMC article.
Cardiometabolic risk reductions in patients with type 2 diabetes mellitus newly treated with a sodium-glucose cotransporter 2 inhibitor versus a dipeptidyl peptidase-4 inhibitor: A real-world administrative database study in Japan.
Kashiwagi A, Shoji S, Kosakai Y, Koga T, Asakawa K, Rokuda M. Kashiwagi A, et al. Among authors: rokuda m. J Diabetes Investig. 2023 Mar;14(3):404-416. doi: 10.1111/jdi.13952. Epub 2022 Dec 14. J Diabetes Investig. 2023. PMID: 36515129 Free PMC article.
Safety and Effectiveness of Peficitinib (ASP015K) in Patients with Rheumatoid Arthritis: Final Results (32 Months of Mean Peficitinib Treatment) From a Long-Term, Open-Label Extension Study in Japan, Korea, and Taiwan.
Takeuchi T, Tanaka Y, Tanaka S, Kawakami A, Song YW, Chen YH, Rokuda M, Izutsu H, Ushijima S, Kaneko Y. Takeuchi T, et al. Among authors: rokuda m. Rheumatol Ther. 2021 Mar;8(1):425-442. doi: 10.1007/s40744-021-00280-5. Epub 2021 Mar 3. Rheumatol Ther. 2021. PMID: 33656739 Free PMC article.
Correction to: Safety and effectiveness of peficitinib (ASP015K) in patients with rheumatoid arthritis: interim data (22.7 months mean peficitinib treatment) from a long-term, open-label extension study in Japan, Korea, and Taiwan.
Takeuchi T, Tanaka Y, Tanaka S, Kawakami A, Song YW, Chen YH, Rokuda M, Izutsu H, Ushijima S, Kaneko Y, Nakashima Y, Shiomi T, Yamada E. Takeuchi T, et al. Among authors: rokuda m. Arthritis Res Ther. 2020 Jun 23;22(1):155. doi: 10.1186/s13075-020-02247-3. Arthritis Res Ther. 2020. PMID: 32576246 Free PMC article.
17 results